Screener
Amphastar Pharmaceuticals AMPH Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's free cash flow?
- Amphastar Pharmaceuticals (AMPH) reported free cash flow of $42.73M in Q2 2026.
- How has Amphastar Pharmaceuticals's free cash flow changed year-over-year?
- Amphastar Pharmaceuticals's free cash flow increased by 70.7% year-over-year, from $25.03M to $42.73M.
- What is the long-term trend for Amphastar Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's free cash flow has grown at a 12.7% compound annual growth rate (CAGR), from $75.19M to $121.23M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Amphastar Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude